BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 24795345)

  • 1. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.
    Suragani RN; Cawley SM; Li R; Wallner S; Alexander MJ; Mulivor AW; Gardenghi S; Rivella S; Grinberg AV; Pearsall RS; Kumar R
    Blood; 2014 Jun; 123(25):3864-72. PubMed ID: 24795345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.
    Suragani RN; Cadena SM; Cawley SM; Sako D; Mitchell D; Li R; Davies MV; Alexander MJ; Devine M; Loveday KS; Underwood KW; Grinberg AV; Quisel JD; Chopra R; Pearsall RS; Seehra J; Kumar R
    Nat Med; 2014 Apr; 20(4):408-14. PubMed ID: 24658078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad2/3-pathway ligand trap luspatercept enhances erythroid differentiation in murine β-thalassaemia by increasing GATA-1 availability.
    Martinez PA; Li R; Ramanathan HN; Bhasin M; Pearsall RS; Kumar R; Suragani RNVS
    J Cell Mol Med; 2020 Jun; 24(11):6162-6177. PubMed ID: 32351032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.
    Tanzi E; Di Modica SM; Bordini J; Olivari V; Pagani A; Furiosi V; Silvestri L; Campanella A; Nai A
    Am J Hematol; 2024 Jul; 99(7):1313-1325. PubMed ID: 38629683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin.
    Carrancio S; Markovics J; Wong P; Leisten J; Castiglioni P; Groza MC; Raymon HK; Heise C; Daniel T; Chopra R; Sung V
    Br J Haematol; 2014 Jun; 165(6):870-82. PubMed ID: 24635723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.
    Dussiot M; Maciel TT; Fricot A; Chartier C; Negre O; Veiga J; Grapton D; Paubelle E; Payen E; Beuzard Y; Leboulch P; Ribeil JA; Arlet JB; Coté F; Courtois G; Ginzburg YZ; Daniel TO; Chopra R; Sung V; Hermine O; Moura IC
    Nat Med; 2014 Apr; 20(4):398-407. PubMed ID: 24658077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice.
    Langdon JM; Barkataki S; Berger AE; Cheadle C; Xue QL; Sung V; Roy CN
    Am J Hematol; 2015 Jan; 90(1):8-14. PubMed ID: 25236856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes.
    Verma A; Suragani RN; Aluri S; Shah N; Bhagat TD; Alexander MJ; Komrokji R; Kumar R
    J Clin Invest; 2020 Feb; 130(2):582-589. PubMed ID: 31961337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis.
    Matte A; De Falco L; Iolascon A; Mohandas N; An X; Siciliano A; Leboeuf C; Janin A; Bruno M; Choi SY; Kim DW; De Franceschi L
    Antioxid Redox Signal; 2015 Dec; 23(16):1284-97. PubMed ID: 26058667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs.
    Longo F; Piolatto A; Ferrero GB; Piga A
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice.
    Wake M; Palin A; Belot A; Berger M; Lorgouilloux M; Bichon M; Papworth J; Bayliss L; Grimshaw B; Rynkiewicz N; Paterson J; Poindron A; Spearing E; Carter E; Hudson R; Campbell M; Petzer V; Besson-Fournier C; Latour C; Largounez A; Gourbeyre O; Fay A; Coppin H; Roth MP; Theurl I; Germaschewski V; Meynard D
    Blood Adv; 2024 Apr; 8(8):1898-1907. PubMed ID: 38241484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
    Rivella S; May C; Chadburn A; Rivière I; Sadelain M
    Blood; 2003 Apr; 101(8):2932-9. PubMed ID: 12480689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles.
    Samakoglu S; Fattori E; Lamartina S; Toniatti C; Stockholm D; Heard JM; Bohl D
    Blood; 2001 Apr; 97(8):2213-20. PubMed ID: 11290581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway.
    De Rosa G; Andolfo I; Marra R; Manna F; Rosato BE; Iolascon A; Russo R
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ineffective erythropoiesis and its treatment.
    Cazzola M
    Blood; 2022 Apr; 139(16):2460-2470. PubMed ID: 34932791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAP-011 improves erythropoiesis in zebrafish model of Diamond-Blackfan anemia through antagonizing lefty1.
    Ear J; Huang H; Wilson T; Tehrani Z; Lindgren A; Sung V; Laadem A; Daniel TO; Chopra R; Lin S
    Blood; 2015 Aug; 126(7):880-90. PubMed ID: 26109203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luspatercept in Myelodysplastic Syndromes: Who and When?
    Komrokji RS
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):393-400. PubMed ID: 32089218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting a new regulator of erythropoiesis to alleviate anemia.
    Paulson RF
    Nat Med; 2014 Apr; 20(4):334-5. PubMed ID: 24710373
    [No Abstract]   [Full Text] [Related]  

  • 20. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.